Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

LUCD

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:LUCD
DateHeureSourceTitreSymboleSociété
14/05/202412h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
14/05/202402h43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
13/05/202414h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
13/05/202414h00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
10/05/202403h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
10/05/202403h57Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
09/05/202413h49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallNASDAQ:LUCDLucid Diagnostics Inc
07/05/202413h39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsNASDAQ:LUCDLucid Diagnostics Inc
02/05/202414h35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
02/05/202413h49PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
29/04/202414h47PR Newswire (US)Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthNASDAQ:LUCDLucid Diagnostics Inc
08/04/202414h30PR Newswire (US)Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LUCDLucid Diagnostics Inc
27/03/202400h32PR Newswire (US)PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
25/03/202422h30PR Newswire (US)Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
21/03/202414h30PR Newswire (US)Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:LUCDLucid Diagnostics Inc
20/03/202413h30PR Newswire (US)Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceNASDAQ:LUCDLucid Diagnostics Inc
12/03/202413h30PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024NASDAQ:LUCDLucid Diagnostics Inc
16/02/202423h00PR Newswire (US)Lucid Diagnostics Provides Update Regarding World Trade Center Health ProgramNASDAQ:LUCDLucid Diagnostics Inc
15/02/202413h45PR Newswire (US)Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyNASDAQ:LUCDLucid Diagnostics Inc
08/02/202413h45PR Newswire (US)Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and SurvivorsNASDAQ:LUCDLucid Diagnostics Inc
06/02/202423h24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LUCDLucid Diagnostics Inc
12/12/202314h30PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility StudiesNASDAQ:LUCDLucid Diagnostics Inc
11/12/202315h00PR Newswire (US)PAVmed Provides Additional Details for Upcoming Stock Dividend to ShareholdersNASDAQ:LUCDLucid Diagnostics Inc
04/12/202322h20PR Newswire (US)PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock SplitNASDAQ:LUCDLucid Diagnostics Inc
16/11/202315h00PR Newswire (US)Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting EffortsNASDAQ:LUCDLucid Diagnostics Inc
14/11/202323h43PR Newswire (US)PAVmed Provides Business Update and Third Quarter Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
13/11/202323h40PR Newswire (US)Lucid Diagnostics Provides Business Update and Third Quarter Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
09/11/202315h00PR Newswire (US)Lucid Diagnostics Launches Next-Generation EsoGuard® Esophageal DNA Test and Announces Upcoming Investor DayNASDAQ:LUCDLucid Diagnostics Inc
02/11/202314h18PR Newswire (US)Lucid Diagnostics to Present at Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services ForumNASDAQ:LUCDLucid Diagnostics Inc
01/11/202321h21Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:LUCDLucid Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:LUCD

Dernières Valeurs Consultées

Delayed Upgrade Clock